• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WIN 55,212-2通过COX-2信号通路抑制胃癌细胞的上皮-间质转化

WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals.

作者信息

Xian Xiangshu, Huang Liuye, Zhang Bo, Wu Chengrong, Cui Jun, Wang Zhihua

机构信息

Department of Gastroenterology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.

出版信息

Cell Physiol Biochem. 2016;39(6):2149-2157. doi: 10.1159/000447910. Epub 2016 Nov 2.

DOI:10.1159/000447910
PMID:27802436
Abstract

BACKGROUND

Cannabinoids (the active components of Cannabis sativa) and their derivatives have received considerable interest due to reports that they can affect the tumor growth, migration, and metastasis. Previous studies showed that the cannabinoid agonist WIN 55,212-2 (WIN) was associated with gastric cancer (GC) metastasis, but the mechanisms were unknown.

METHODS

The effects of WIN on GC cell migration and invasion were analyzed by the wound-healing assay and Transwell assay. Quantitative real-time PCR and Western blot were used to evaluate changes in expression of COX-2 and EMT associated markers in SGC7901 and AGS cells.

RESULTS

WIN inhibited cell migration, invasion, and epithelial to mesenchymal transition (EMT) in GC. WIN treatment resulted in the downregulation of cyclooxygenase-2 (COX-2) expression and decreased the phosphorylation of AKT, and inhibited EMT in SGC7901 cells. Decreased expression of COX-2 and vimentin, and increased expression of E-cadherin, which was induced by WIN, were normalized by overexpression of AKT, suggesting that AKT mediated, at least partially, the WIN suppressed EMT of GC cells.

CONCLUSION

WIN can inhibit the EMT of GC cells through the downregulation of COX-2.

摘要

背景

大麻素(大麻的活性成分)及其衍生物因有报道称它们可影响肿瘤生长、迁移和转移而受到广泛关注。先前的研究表明,大麻素激动剂WIN 55,212-2(WIN)与胃癌(GC)转移有关,但其机制尚不清楚。

方法

采用划痕实验和Transwell实验分析WIN对GC细胞迁移和侵袭的影响。运用定量实时PCR和蛋白质免疫印迹法评估SGC7901和AGS细胞中COX-2及上皮-间质转化(EMT)相关标志物表达的变化。

结果

WIN抑制GC细胞的迁移、侵袭及上皮-间质转化(EMT)。WIN处理导致环氧化酶-2(COX-2)表达下调,AKT磷酸化水平降低,并抑制SGC7901细胞的EMT。WIN诱导的COX-2和波形蛋白表达降低以及E-钙黏蛋白表达增加,通过AKT过表达得以恢复正常,这表明AKT至少部分介导了WIN对GC细胞EMT的抑制作用。

结论

WIN可通过下调COX-2抑制GC细胞的EMT。

相似文献

1
WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals.WIN 55,212-2通过COX-2信号通路抑制胃癌细胞的上皮-间质转化
Cell Physiol Biochem. 2016;39(6):2149-2157. doi: 10.1159/000447910. Epub 2016 Nov 2.
2
CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.癌胚抗原相关细胞黏附分子6通过PI3K/AKT信号通路诱导上皮-间质转化,从而促进胃癌的侵袭和转移。
PLoS One. 2014 Nov 14;9(11):e112908. doi: 10.1371/journal.pone.0112908. eCollection 2014.
3
Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.黄芪甲苷通过抑制 PI3K/Akt/NF-κB 通路抑制 TGF-β1 诱导的胃癌细胞上皮-间质转化。
Phytother Res. 2018 Jul;32(7):1289-1296. doi: 10.1002/ptr.6057. Epub 2018 Feb 26.
4
F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.F-box 蛋白 11 通过 PI3K/AKT 通路介导的 EMT 促进胃癌的生长和转移。
Biomed Pharmacother. 2018 Feb;98:416-423. doi: 10.1016/j.biopha.2017.12.088. Epub 2017 Dec 27.
5
Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.肝细胞生长因子上调通过 Akt 和 COX-2 通路促进肝癌的发生发展和上皮间质转化。
Clin Exp Metastasis. 2011 Dec;28(8):721-31. doi: 10.1007/s10585-011-9404-x. Epub 2011 Jul 10.
6
Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement.Notch1 和 PI3K/Akt 信号通路阻断剂 DAPT 和 LY294002 通过相互增强协同抑制胃癌转移。
Cancer Chemother Pharmacol. 2020 Feb;85(2):309-320. doi: 10.1007/s00280-019-03990-4. Epub 2019 Nov 16.
7
miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.miR-300 通过靶向 FAK/PI3K/AKT 信号通路调节肝癌的上皮-间充质转化和侵袭。
Biomed Pharmacother. 2018 Jul;103:1632-1642. doi: 10.1016/j.biopha.2018.03.005. Epub 2018 May 7.
8
BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.BMP2 通过激活磷脂酰肌醇 3-激酶(PI3K)/Akt 通路加速胃癌细胞的迁移和侵袭。
Exp Cell Res. 2010 Jan 1;316(1):24-37. doi: 10.1016/j.yexcr.2009.10.010. Epub 2009 Oct 14.
9
[Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells].[大麻素WIN55,212-2抑制人SMMC-7721肝癌细胞的增殖、侵袭和迁移]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 May;32(5):619-24.
10
ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.锌指蛋白143通过PI3K/AKT信号通路促进上皮-间质转化过程,从而增强胃癌的转移能力。
Tumour Biol. 2016 Sep;37(9):12813-12821. doi: 10.1007/s13277-016-5239-z. Epub 2016 Jul 23.

引用本文的文献

1
Pro-Apoptotic Effects of Anandamide in Human Gastric Cancer Cells Are Mediated by AKT and ERK Signaling Pathways.花生四烯酸乙醇胺对人胃癌细胞的促凋亡作用由AKT和ERK信号通路介导。
Int J Mol Sci. 2025 Feb 26;26(5):2033. doi: 10.3390/ijms26052033.
2
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.大麻素类药物作为有前景的抗癌药物:在健康细胞和癌细胞中的作用机制。
Adv Exp Med Biol. 2023;1410:145-169. doi: 10.1007/5584_2022_748.
3
Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges.
大麻素的抗菌和细胞毒性作用:具有未来展望和当前挑战的最新综述
Pharmaceuticals (Basel). 2022 Oct 6;15(10):1228. doi: 10.3390/ph15101228.
4
Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.内源性大麻素系统与肿瘤微环境:抗癌方法的新交织联系。
Cells. 2021 Dec 2;10(12):3396. doi: 10.3390/cells10123396.
5
Cannabinoids in the landscape of cancer.大麻素在癌症领域的应用。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2507-2534. doi: 10.1007/s00432-021-03710-7. Epub 2021 Jul 14.
6
Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.大麻素 WIN 55,212-2 通过触发 ROS 介导的信号通路抑制人神经胶质瘤细胞生长。
Biomed Res Int. 2021 Apr 22;2021:6612592. doi: 10.1155/2021/6612592. eCollection 2021.
7
Molecular Mechanism of Cannabinoids in Cancer Progression.大麻素在癌症进展中的分子机制
Int J Mol Sci. 2021 Apr 1;22(7):3680. doi: 10.3390/ijms22073680.
8
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.大麻素和合成大麻素在临床实验模型中的新兴作用。
Adv Exp Med Biol. 2021;1264:47-65. doi: 10.1007/978-3-030-57369-0_4.
9
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.大麻素受体在非小细胞肺癌中的表达。四氢大麻酚和大麻二酚抑制体外细胞增殖和上皮-间充质转化的效果。
PLoS One. 2020 Feb 12;15(2):e0228909. doi: 10.1371/journal.pone.0228909. eCollection 2020.
10
WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner.WIN55,212-2 诱导的 Mir-29b1 表达以 SPARC 非依赖的方式有利于抑制骨肉瘤细胞迁移。
Int J Mol Sci. 2019 Oct 22;20(20):5235. doi: 10.3390/ijms20205235.